Holding(s) in Company

RNS Number : 5075H
Dechra Pharmaceuticals PLC
16 March 2015
 



 

TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi



1. Identity of the issuer or the underlying issuer
of existing shares to which voting rights are
attached:

Dechra Pharmaceuticals PLC

2 Reason for the notification (please tick the appropriate box or boxes):

An acquisition or disposal of voting rights


An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached


An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments


An event changing the breakdown of voting rights


Other (please specify):

This is a clarification of the number of voting right shares held by the Aberdeen Asset Management PLC Group, in its capacity as discretionary asset manager.  Previous notifications have been submitted on an all share capital basis (inclusive of shares held without voting powers being delegated to Aberdeen Asset Management PLC Group).  This notification does not reflect any changes in shareholdings, and is purely a clarification exercise to confirm the voting rights held. Any such future notifications, as may be required, will be made on a voting rights basis only

X

3. Full name of person(s) subject to the
notification obligation:

Aberdeen Asset Managers Limited (and/or acting for its affiliates) as discretionary investment manager on behalf of multiple managed portfolios

4. Full name of shareholder(s)
 (if different from 3.):

N/a

5. Date of the transaction and date on
which the threshold is crossed or
reached:


6. Date on which issuer notified:

13 March 2015

7. Threshold(s) that is/are crossed or
reached:

5%

8. Notified details:

A: Voting rights attached to shares

Class/type of
shares


if possible using
the ISIN CODE

Situation previous
to the triggering
transaction

Resulting situation after the triggering transaction

Number
of
Shares

Number
of
Voting
Rights

Number
of shares

Number of voting
rights

% of  voting rights


Direct

Indirect

Direct

Indirect

 

GB0009633180

6,491,579

6,363,032

6,491,579


6,363,032


7.23%

 



B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financial
instrument

Expiration
date

Exercise/
Conversion Period

Number of voting
rights that may be
acquired if the
instrument is
exercised/ converted.

% of voting
rights







C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi

Resulting situation after the triggering transaction

Type of financial
instrument

Exercise price

Expiration date

Exercise/
Conversion period

Number of voting rights instrument refers to

 

% of voting rights





 

 

Nominal

Delta



 

 

 

Total (A+B+C)

Number of voting rights

Percentage of voting rights

      6,363,032

 

         7.23%

 

 

 

9. Chain of controlled undertakings through which the voting rights and/or the
financial instruments are effectively held, if applicable:

 

 


Proxy Voting:

10. Name of the proxy holder:


11. Number of voting rights proxy holder will cease
to hold:


12. Date on which proxy holder will cease to hold
voting rights:




13. Additional information:



14. Contact name:

 

Ben Van Loon

15. Contact telephone number:

 

01224 404090

 

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLDMGMFRVZGKZG
UK 100

Latest directors dealings